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ABSTRACT
Objective To quantify psychosocial risk in family
caregivers of children with medical complexity using the
Psychosocial Assessment Tool (PAT) and to investigate
potential contributing sociodemographic factors.
Design Cross-sectional study.
Setting Family caregivers completed questionnaires
during long-term ventilation and complex care clinic visits
at The Hospital for Sick Children, Toronto, Ontario, Canada.
Patients A total of 136 family caregivers of children with
medical complexity completed the PAT questionnaires from
30 June 2017 through 23 August 2017.
Main outcome measures Mean PAT scores in
family caregivers of children with medical complexity.
Caregivers were stratified as ‘Universal’ low risk, ‘Targeted’
intermediate risk or ‘Clinical’ high risk. The effect of
sociodemographic variables on overall PAT scores was
also examined using multiple linear regression analysis.
Comparisons with previous paediatric studies were made
using T-test statistics.
Results 136 (103 females (76%)) family caregivers
completed the study. Mean PAT score was 1.17 (SD=0.74),
indicative of ‘Targeted’ intermediate risk. Sixty-one (45%)
caregivers were classified as Universal risk, 60 (44%) as
Targeted risk and 15 (11%) as Clinical risk. Multiple linear
regression analysis revealed an overall significant model
(p=0.04); however, no particular sociodemographic factor
was a significant predictor of total PAT scores.
Conclusion Family caregivers of children with medical
complexity report PAT scores among the highest of all
previously studied paediatric populations. These caregivers
experience significant psychosocial risk, demonstrated by
larger proportions of caregivers in the highest-risk Clinical
category.

INTRODUCTION
Children with medical complexity (CMC)1 2
are defined by medical fragility, dependence
on technology at home and substantial care
needs.3 An estimated 0.4%–0.7% of children
in the USA and Canada meet the definition
for CMC; however, their healthcare costs
account for approximately one-
third of all
child health spending.4 5 Family caregivers
(FCs) of CMC are an essential population
of caregivers with unique challenges. These
include prolonged hospitalisations,6 poor

What is known about the subject?
►► Children with medical complexity are a growing

population with disproportionate uses of healthcare
resources.
►► Caregivers of these children experience unique
challenges including maintenance of technology at
home, poor care coordination with multiple health
providers and prolonged hospitalisations.
►► Despite children with medical complexity accounting
for 43% of all paediatric deaths in the USA, caregiver psychosocial risk in this population has not been
quantitatively studied.

What this study adds?
►► The prevalence of psychosocial risk in families car-

ing for children with medical complexity are among
the highest of all previously studied paediatric
populations.
►► Being able to quantify a caregiver’s level of risk will
ensure appropriate social support and resource allocation to at-risk families.

care coordination7 and the expectation of
always being ‘on call’ where short delays in
recognition and response to emergency situations can have deleterious consequences.8
As many of these conditions are diagnosed
in infancy, FCs may be tasked with sustaining
caregiver demands for decades as both
parents and healthcare providers.9 Altogether, these enormous challenges result in
extensive caregiver stress with negative physical and emotional consequences, which may
then seriously impact their ability to care for
their child.10–14
Despite CMC in the USA accounting for
43% of paediatric deaths, 49% of paediatric
hospitalisation days and 73%–92% of assistive
health technology (eg, tracheostomy, gastrostomy tube) use in children,15 16 existing literature on psychosocial risk of caregivers of CMC
is limited primarily to qualitative studies.1 17–19
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METHODS
Study design and setting
This single-centre, cross-sectional study was conducted
at the Hospital for Sick Children (SickKids), Toronto,
Canada. Study participants were recruited from 30 June
2017 to 23 August 2017. This study was written in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology statement (online supplementary appendix 1).
Patient and public involvement
Patients were not involved in the design and/or conduct
of this study.
Study participants
The inclusion criteria was as follows: (1) FC of a child aged
<18 years satisfying the Provincial Council for Maternal
and Child Health Standard Operational Definition
for CMC who are medically fragile and/or technology
dependent3 and (2) the children were followed in the
long-term ventilation and/or complex care programmes.
The exclusion criteria was failure to consent for the study
by the parent or authorised caregiver and caregivers
unable to complete the questionnaire in English.
Study measures
Demographic and socioeconomic review
Health records were retrospectively reviewed for study
participants’ children capturing their age, gender,
primary medical diagnosis (adapted from Wallis et al26),
date of diagnosis, medications, medical technologies
used at home, community supports and healthcare utilisation (ie, length of hospital admission in the past year).
Community supports included the number of nursing
and personal support worker hours per week, respite
admissions per year and other homecare and/or income
supports.
The PAT
The Psychosocial Assessment Tool (PAT) is a brief parent-
reported screening tool for measuring psychosocial risk in
caregivers of paediatric patients.27 Originally developed
in paediatric oncology, the modified PAT questionnaire
2

(PATrev) has been used to study other paediatric populations.24 28–31 The 15-item PAT questionnaire is completed
in 5–10 min and assesses seven subscales: family structure/
resources, social support, patient/child problems, sibling
problems, caregiver problems, caregiver stress reactions
and family beliefs. For this study, prompts related to a
cancer diagnosis were removed from questions 9 and 15
of the PAT after consultation with the original PAT developers. The complete PAT is shown in online supplementary appendix 2.
Study procedures
Eligible caregivers were approached during scheduled clinic visits by the attending physician. Those who
expressed interest were then invited to meet with the
Research Assistant to obtain further details and provide
written consent. All PAT questionnaires were filled out
on paper in-person by caregivers themselves. PAT questionnaires were scored within 24 hours of completion.
Final scores for the seven subscales were calculated via
the summation of the risk factors endorsed by FC, divided
by the total number of risk items for the sub-scale. The
total PAT score was then derived from the sum of all
seven subscale scores. Based on The Pediatric Psychosocial Preventative Health Model (PPPHM), the total PAT
score stratifies FCs into three levels of psychosocial risk:
low-risk ‘Universal’ families with normal transient levels
of stress (total score <1.0), intermediate-risk ‘Targeted’
families with acute or elevated levels of stress (total score
between 1.0 and 1.9) and high-risk ‘Clinical’ families with
severe stress (total score ≥2.0).24 32
Statistical analysis
Clinical and demographic characteristics of participating children and FCs were summarised with descriptive statistics. For the primary analysis, the prevalence of
psychosocial risk in each of the three risk categories was
calculated as a percentage of all FCs using the total PAT
scores. To compare the PAT scores from caregivers of
ventilated children with those of non-ventilated children,
a Mann-Whitney Wilcoxon test was conducted. Previous
studies using the PAT score were found by conducting a
search of online databases Ovid MEDLINE and Web of
Science from inception to 28 April 2020 using keywords
‘Psychosocial Assessment Tool’, ‘caregiver’ and ‘pediatrics’. Included studies measured the psychosocial risk in
caregivers of specific paediatric populations using the
PAT. Independent t-tests were then used to compare the
mean PAT scores between each study and the current
study; p values were corrected using the Šidák correction
for multiple comparisons.
For the secondary analysis, linear regression was used
to explore predictors of psychosocial risk in caregivers
at the time of their clinic visit; the variables tested were
not scored within the PAT and included sex of both
the child and caregiver, child age, number of caregivers
at home, employment status, annual family income,
hours/week of paid homecare support, CMC’s hospital

Verma R, et al. BMJ Paediatrics Open 2020;4:e000671. doi:10.1136/bmjpo-2020-000671

bmjpo: first published as 10.1136/bmjpo-2020-000671 on 27 July 2020. Downloaded from http://bmjpaedsopen.bmj.com/ on July 4, 2022 by guest. Protected by copyright.

Identified risk factors include the child’s dependence
on assistive technology,20 presence of other children at
home,20 limited financial resources21 and poor social
supports.12 13 However, there remains a need to quantitatively measure the psychosocial risk of FCs of CMC similar
to previous studies in children with oncological, renal,
gastrointestinal and cardiac diseases.22–24 As with these
studies, systematic screening of FCs of CMC may facilitate
early intervention and appropriate allocation of social
support resources to those at highest need. Enhancing
the care of CMC remains an urgent priority.5 25 Our aim
was to quantify psychosocial risk in FCs of CMC and investigate sociodemographic factors that may identify families at greatest risk.

Open access

RESULTS
One hundred seventy-
nine families were eligible for
recruitment. Of these families, 2 were not approached
at the request of the clinicians, while another 13 were
missed due to scheduling conflicts. The remaining 164
families were approached for participation. Twenty-three
families (14%) declined, citing lack of interest and/or
time as primary reasons. Five caregivers (3%) requested
to take home the questionnaires but did not return them.
Overall, 136 (83%) of the 164 caregivers completed the
questionnaires. These questionnaires contained no
missing details.
The demographic information for FCs and CMC is
presented in tables 1 and 2. FCs had a mean age of 42
years (SD 8.5 years). Seventy-six per cent were females
(n=103), 23% were males (n=32) and one FC did not
report their sex. Seventy-four FCs (54%) reported some
degree of financial difficulty at home. Of the 136 children,
the mean age was 9 years (SD 5.3 years). Seventy-eight
CMC (57%) received long-term mechanical ventilation
(invasive or non-invasive) at home.
Prevalence of psychosocial risk
Total PAT scores ranged from 0.00 to 3.92 (mean=1.17,
median=1.13, SD=0.74). The most endorsed PAT items by
FCs of CMC were child problems, caregiver problems and
caregiver stress reactions. The least reported items were
social support and sibling problems. Table 3 contains the
final scores and subscale scores for all included FCs.
Of all 136 FCs, 45% (n=61) fell into the Universal
low-
risk category, 44% (n=60) fell into the Targeted
intermediate-risk category and 11% (n=15) fell into the
Clinical high-risk category. Caregivers of ventilated children reported a mean PAT score of 1.29 (SD=0.83) and
FCs of non-
ventilated children reported a mean PAT
score of 1.00 (SD=0.57). This difference was not significant (p=0.06).
Our search identified 28 previous studies that used the
PAT in children (table 4). In comparison to these studies,
FCs of our CMC population have the third highest overall
PAT scores. Our mean PAT score is significantly higher
than 14 of the 26 studies from which we were able to
perform our analysis (p<0.05).
Verma R, et al. BMJ Paediatrics Open 2020;4:e000671. doi:10.1136/bmjpo-2020-000671

Table 1 Demographic characteristics of the 136 family
caregivers included in this study
Gender
 Female
 Male
 Did not disclose

n=136
103 (76%)
32 (23%)
1 (1%)

Age (years)
 20–29

6 (4%)

 30–39

46 (34%)

 40–49

56 (41%)

 50–59

19 (14%)

 60–69

3 (2%)

 70–79

1 (1%)

 Did not disclose

5 (4%)

Ethnicity (mother)
 European

57 (42%)

 Asian

50 (37%)

 Caribbean/Indian-Caribbean

11 (8%)

 Other

11 (8%)

 African

7 (5%)

Ethnicity (father)
 European

55 (40%)

 Asian

46 (34%)

 Other

15 (11%)

 Caribbean/Indian-Caribbean

12 (9%)

 African

8 (6%)

Marital status
 Single or separated

31 (23%)

 Married/Partnered

104 (76%)

 Did not disclose

1 (1%)

Education
 Started high school

7 (5%)

 Graduated high school

19 (14%)

 Some tertiary study

23 (17%)

 Finished college or trade school

68 (50%)

 Finished Master’s or Doctoral
programme

17 (13%)

 Did not disclose

2 (1%)

Relation to child
 Biological parent

126 (93%)

 Grandparent

4 (3%)

 Foster parent

3 (2%)

 Aunt/Uncle/Other relative

2 (1%)

 Step parent

1 (1%)

Role with child
 Primary (daily) caregiver
 Supporting/Back-up caregiver

128 (94%)
5 (4%)
Continued
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admission days in the previous year and the number
of medical technologies. Variables with p<0.2 at the
bivariate level were entered into a multiple regression
analysis; multicollinearity was checked using the variance inflation factor. A backward selection method was
used to eliminate variables that had least significance
and did not impact the estimates of other variables in
the model by 10%. Statistical analysis was performed
using SAS V.9.3 (SAS Institute, Cary, North Carolina,
USA). The level of significance was set at p<0.05 for all
analyses.

Open access

 Occasional caregiver

2 (1%)

 Other

1 (1%)

Table 2 Demographic and disease characteristics of the
136 children with medical complexity at the time of their
clinic visit

Caregivers at home
 1

17 (12%)

 2

95 (70%)

 ≥3

24 (18%)
27 (20%)

 30 000–79 999

49 (36%)

 80 000–149 999

29 (21%)

 ≥150 000

11 (8%)

 Did not disclose

20 (15%)

n=136
86 (63%)

 Female

50 (37%)

Age (years)

After-tax income (US$)
 <30 000

Gender
 Male

 0–4

34 (25%)

 5–9

33 (24%)

 10–14

39 (29%)

 15–18

30 (22%)

Primary diagnosis
 Central nervous system (n=38%–28%)
  Congenital central hypoventilation
syndrome

9 (7%)

54 (40%)

  Spinal injury

6 (4%)

 Part-time

13 (9%)

  Birth injury/cerebral palsy

5 (4%)

 Unemployed

42 (31%)
27 (20%)

  Acquired central hypoventilation
syndrome

3 (2%)

 Did not disclose

Employment status
 Full-time

  Other central causes

Financial difficulty

15 (11%)

 No problems

62 (46%)

 Musculoskeletal (n=82%–61%)

 Some problems
 Difficulty meeting family needs

49 (36%)
25 (18%)

  Duchenne’s muscular dystrophy

19 (14%)

  Other dystrophy

18 (13%)

  Spinal muscular atrophy

13 (10%)

Predictors of psychosocial risk
The initial univariate analysis revealed FC sex (p=0.03),
length of hospitalisations (p=0.04), FC employment status
(p=0.04), number of medical technologies (p=0.08) and
hours of paid homecare support (p=0.1) to be likely
predictors of PAT scores (p<0.2). These variables were
then entered into the multiple regression analysis. The
results indicate an overall significant model; however,
none of FC sex (p=0.2), length of hospitalisations (p=0.3),
FC employment status (p=0.07), number of medical
technologies (p=0.8) or paid homecare support (p=0.4)
contributed significantly to the model (p>0.05). Results
of the regression analysis are displayed in table 5. Therefore, these sociodemographic factors were not significant
predictors of caregivers’ overall PAT scores.

  Congenital myopathy

8 (6%)

  Other myopathy

8 (6%)

  Mucopolysaccharidoses

3 (2%)

  Other musculoskeletal

13 (10%)

 Respiratory (n=10%–7%)
  Upper airway obstruction

4 (3%)

  Chronic lung disease

3 (2%)

  Airway malacia

1 (1%)

  Other respiratory

2 (1%)

 Unclassified (n=6%–4%)
Days in hospital in the past 12 months
 0–1

81 (59%)

 2–10

34 (26%)

 >10

21 (15%)

Paid homecare support* (hours/week)

DISCUSSION
We found that FCs of CMC suffer significant psychosocial
risk demonstrated by an overall PAT score of 1.17 and
more than 1 in 10 caregivers scoring in the high-risk category. Our findings also suggest that chronic ventilation at
home may add another layer of stress to caregivers. Additionally, the included sociodemographic factors were not
found to be significant predictors of the total PAT score.
Compared
with
previous
studies
in
children,22–24 27 29–31 33–53 the distribution of PAT scores for FCs
of CMC is substantially weighted towards the higher risk
categories (45% Universal, 44% Targeted, 11% Clinical).
4

 0

73 (54%)

 1–19

14 (10%)

 20–49

27 (20%)

 >50

22 (16%)

Number of technologies
 0–1

37 (27%)

 2–4

57 (42%)

 ≥5
Technology

42 (31%)
Continued
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Table 1 Continued
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 Oxygen saturation monitor

79 (58%)

 Wheelchair

79 (58%)

 BiPAP (nocturnal)

52 (38.%)

 Cough assist

51 (38%)

 Suction

49 (36%)

 Gastrostomy tube

37 (27%)

 Supplemental oxygen (nocturnal/
naps)

19 (14%)

 Trach/Vent (nocturnal/naps)

18 (13%)

 Gastrojejunostomy tube

17 (13%)

 Trach/Vent (24 hours/day)

9 (7%)

 Trach only

6 (4%)

 Supplemental oxygen (24 hours)

3 (2%)

 Ventriculoperitoneal shunt

3 (2%)

 CPAP

2 (1%)

 Lifting device

2 (1%)

 Sip ventilation
 Port-a-Cath

1 (1%)
1 (1%)

*Homecare supports included the number of nursing and personal
support worker hours per week.
BiPAP, Bilevel positive airway pressure; CPAP, continuous positive
airway pressure; Trach/Vent, tracheostomy and ventilation.

The first paediatric studies using PAT questionnaires in
children with cancer categorised 50%–72% of FCs as
Universal risk, 24%–41% as Targeted risk and 4%–9%
as Clinical risk.22 27 34 35 These scores are notably lower
than those seen in our study. Only two previous paediatric studies on sickle cell disease29 36 and one on stem
cell transplant recipients43 reported even higher Clinical-
risk families. In the CMC population, the higher proportion of families in the Clinical group may be attributed to
intense stressors ranging from acute care admissions to
clinic appointments, prolonged hospitalisations, ordering
of medical equipment for their child, uncertainty of life
expectancy and time spent by caregivers advocating for
resources.13 19 54 These stressors often have emotional and
financial implications such as marriage breakdowns and

employment changes.55 56 Some caregivers are even diagnosed with post-traumatic stress disorder.9
Higher PAT scores among FCs of CMC may also be
explained by the chronicity of their healthcare needs.
This is unique from other populations such as children
with oncologic conditions where there is a relatively
acute stage of intense stress.57 Families of CMC are tasked
with these overwhelming duties for years leading to
persistently increased caregiver psychosocial risk. Interestingly, FCs of CMC also have higher reported PAT
scores than other chronic paediatric diseases such as children with sickle cell disease, congenital heart disease and
renal failure. This may be attributed to the use of assistive
technologies at home that has been previously identified
as a risk factor to a caregiver’s psychosocial risk.20
In our study, we found that families caring for CMC
receiving long-term mechanical ventilation at home may
be at an even greater psychosocial risk. These caregivers
reported higher PAT scores than those of children who
were not ventilated; however, this difference was not
significant (p=0.06). Previous studies have described the
additional challenges experienced by parents of ventilated children.12 13 19 21 54 These include more provider
visits for ventilator care and constant anxiety about
ventilator malfunction.54 Caregivers of children on ventilator support also report offensive reactions from their
everyday community devaluing their child’s life as a ‘life
not worth maintaining’.21 This leads to social avoidance
and further isolates these families. Thus, psychosocial
risk in this subgroup of FCs needs to be further studied as
these caregivers may require additional social assistance
compared with caregivers of CMC using other assistive
technologies.
We did not observe a significant association between
caregivers’ sociodemographic factors and their overall
PAT scores. There are limited paediatric studies that have
examined this relationship.23 37 39 42 For example, Hearps
et al23 investigated caregivers of children with congenital
heart disease and found only lower parental education
attainment to be a significant predictor of higher PAT
scores. Parental education was also deemed significant
in two other studies of children with cystic fibrosis39 and
cancer.37 To the best of our knowledge, this relationship

Table 3 Descriptive statistics for PAT total scores and subscale scores (n=136)
PAT scale (items)

Scale range

Mean

SD

Range

Total
Family structure/resources(education, marital status, 1, 3, 6, 7)

0–7
0–7

1.17
0.17

0.74
0.16

0–3.92
0–0.71

Social support (2a-d)

0–4

0.09

0.22

0–1.00

0–16

0.29

0.20

0–0.88

0–20

0.08

0.13

0–0.69

0–10

0.22

0.19

0–0.90

0–5
0–12

0.20
0.12

0.29
0.11

0–1.00
0–0.67

Child problems

(9a-d, k-u, w)

Sibling problems(10a-d, g-u, w)
Caregiver problems

(11a-e, g-j, l)

Caregiver stress reactions
Family beliefs(14a-l)

(12a-e)

PAT, Psychosocial Assessment Tool.
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Universal n
(%)

Targeted n
(%)

Clinical n
(%)

Mean PAT 95% CI of the
score
difference

61 (45%)

60 (44%)

15 (11%)

1.17

63 (46%)

54 (40%)

19 (14%)

1.15

0.16 to 0.20

0.8

Sharkey et al, Cancer
n=26237

NR

NR

NR

1.02

0.00 to 0.30

0.05

Tsumura et al, Cancer
n=11738

NR

NR

NR

1.45

−0.48 to 0.0.8

0.006

Filigno et al,
n=15439

Cystic fibrosis

80 (52%)

63 (41%)

11 (7%)

1.00

0.00 to 0.34

0.05

Kapa et al,
n=21740

Craniofacial

NR

NR

NR

0.91

0.10 to 0.42

0.001

Law et al,
n=23541

Headache

134 (57%)

82 (35%)

19 (8%)

0.99

0.04 to 0.33

0.02

Rocque et al, Brain tumour
n=4042

24 (60%)

15 (38%)

1 (2%)

0.89

0.03 to 0.52

0.03

Pai et al,
n=14043

Stem cell
transplant

76 (54%)

42 (30%)

22 (16%)

1.14

−0.15 to 0.21

0.7

Schulte et al,
n=9544

Cancer

NR

NR

NR

0.84

0.14 to 0.52

<0.001

Crerand et al, Craniofacial
n=21745

130 (60%)

70 (32%)

17 (8%)

0.91

0.11 to 0.41

<0.001

Ernst et al
n=19746

Disorders
of sexual
development

130 (66%)

55 (28%)

12 (6%)

0.86

0.16 to 0.46

<0.001

Kazak et al,
n=39447

Cancer

246 (62%)

106 (27%)

42 (11%)

0.97

0.06 to 0.34

0.005

Cousino et al, Heart transplant
n=5648

33 (59%)

17 (30%)

6 (11%)

0.96

0.02 to 0.44

0.08

Phan et al,
n=10031

Obesity

7 (27%)

17 (65%)

2 (8%)

1.20

−0.20 to 0.14

0.7

Woods and
Ostrowski-
Delahanty
n=12749

Headache

NR

NR

NR

1.12

−0.12 to 0.22

0.6

Clapin et al,
n=4950

Type 1 diabetes

NR

NR

NR

1.00

0.07 to 0.41

0.2

Pierce et al,
n=6751

Cancer

42 (63%)

21 (31%)

4 (6%)

0.90

0.06 to 0.48

0.01

McCarthy et
al,
n=8952

Cancer

51 (57%)

34 (38%)

4 (5%)

1.00

−0.01 to 0.35

0.07

Sint Nicolaas
et al,
n=11753

Cancer

77 (66%)

34 (29%)

6 (5%)

0.80

0.20 to 0.54

<0.001

Pai et al,
n=4230
Barrera et al,
n=6722

Inflammatory
bowel disease
Cancer

27 (64%)

15 (36%)

0 (0%)

0.77

0.21 to 0.59

<0.001

40 (60%)

21 (31%)

6 (9%)

NR

Study

Population

Verma et al
(this study),
n=136
Reader et al,
n=13636

Children
with medical
complexity
Sickle cell
disease

P value

Continued
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Universal n
(%)

Targeted n
(%)

Clinical n
(%)

Mean PAT 95% CI of the
score
difference

Congenital heart
disease

24 (62%)

14 (36%)

1 (2%)

0.81

0.14 to 0.58

Karlson et al,
n=21929

Sickle cell
disease

109 (50%)

80 (36%)

30 (14%)

1.12

−0.11 to 0.21

0.5

Pai et al,
n=4524

Kidney transplant NR

NR

NR

0.98

−0.06 to 0.44

0.1

Kazak et al,
n=5033

Cancer

36 (72%)

12 (24%)

2 (4%)

0.76

0.20 to 0.62

<0.001

McCarthy et
al,
n=22034

Cancer

147 (67%)

52 (24%)

21 (9%)

0.93

0.21 to 0.51

<0.001

51 (50%)

42 (41%)

9 (9%)

NR

122 (59%)

65 (32%)

18 (9%)

1.02

−0.01 to 0.31

0.07

Study

Population

Hearps et al,
n=3923

Alderfer et al, Cancer
n=10235
Cancer
Pai et al,
n=20527

P value
0.001

P values were obtained by performing independent t-tests to compare each study with the current study; p values were corrected using the
Šidák correction for multiple comparisons.
.NR, not reported; PAT, Psychosocial Assessment Tool.

has not been previously examined in CMC using the
PAT. In our model, we did not include the caregiver’s
level of education as this variable is inherently included
within our PAT questionnaire. Our results are in accordance with another recent study by Rocque et al42 that
investigated children with brain tumours. As in our study,
demographic factors were not found to be significantly
predictive of PAT scores. Since our overall model was
determined to be significant, sociodemographic factors
have some contribution to overall PAT scores. However,
we emphasise to clinicians caring for CMC that no one
particular demographic characteristic can be used to
identify families at greatest psychosocial risk. Altogether,

this further underscores the importance of an objective
screening measure to identify these caregivers, such as
the PAT.
Our study has some notable limitations. First, as a
single-centre study, our findings may not be generalisable to all institutions in the USA and Canada. Second,
despite the high level of caregiver enrolment in this study
(83%), the level of psychosocial risk in those who did not
participate remains unknown and introduces the risk for
participation bias. It may be possible that families unable
to attend their scheduled clinic visit or those with limited
English proficiency may be experiencing more stress
than the caregivers sampled. Third, as the majority of

Table 5 Summary of multiple regression analysis of caregivers’ sociodemographic factors on total PAT scores
Variable

B coefficient

SE

95% CI

P value

Child’s hospitalisation days in previous year (0–1 days)
Child’s hospitalisation days in previous year (2–10 days)

−0.30
−0.28

0.19
0.21

−0.68 to 0.08
−0.69 to 0.13

0.1
0.2

Child’s hospitalisation days in previous year (>10 days)

Reference

–

–

–

Paid homecare support (0 hours/week)

−0.37

0.22

−0.81 to 0.07

0.1

Paid homecare support (1–19 hours/week)

−0.30

0.26

−0.83 to 0.22

0.3

Paid homecare support (20–49 hours/week)

−0.23

0.22

−0.65 to 0.20

0.3

Paid homecare support (>50 hours/week)

Reference

–

–

–

Caregiver employment status (full-time)

−0.21

0.17

−0.55 to 0.14

0.2

Caregiver employment status (part-time)

−0.30

0.24

−0.78 to 0.18

0.2

Caregiver employment status (unemployed)

0.16

0.18

−0.20 to 0.52

0.4

Caregiver employment status (did not disclose)

Reference

–

–

–

Caregiver sex
Number of medical technologies

0.19
−0.01

0.16
0.41

−0.12 to 0.50
−0.09 to 0.07

0.2
0.8

PAT, Psychosocial Assessment Tool.
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